Freemelt - Setting up for a transformational year
2023-11-09 07:52:00
Redeye updates its estimates and valuation following Freemelt’s Q3 report, which came in somewhat weaker than expected in terms of sales. Although softer numbers than expected, the highlight since the last quarterly report is undoubtedly the commercial agreement for the industrial printer eMELT. With the commercialization of eMELT, we argue 2024 will be a transformational year for the company.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/